The PGY2 Critical Care residency program is designed to provide the resident with a solid foundation of experiences focusing on critical care pharmacotherapy. The resident will have access to over 170 ICU beds in 5 distinct ICU settings providing residents with excellent subspecialty learning opportunities. There are 5 clinical core rotations in the cardiac, cardiovascular surgery, medical, neurosurgical, and general surgery and liver ICUs. Two additional months are dedicated to research/management rotations. Two elective rotations can also be selected internally or at off-site locations. The program is tailored to meet each resident’s needs offering a diverse range of critical care rotation experiences including exposure to transplant patients (heart, lung, kidney, liver, and pancreas), mechanical circulatory support devices (ECMO, VAD, Impella®, intra-aortic balloon pump, artificial heart, etc.), and research and quality improvement opportunities. The resident can repeat a core ICU rotation or can choose from other internal elective rotations including bone marrow transplant, emergency department, infectious diseases, mechanical circulatory devices, and solid organ transplant. Potential external elective rotations are subject to availability and include academia, pediatric ICU, medical ICU at one of our community hospitals (Houston Methodist Sugar Land Hospital), neuro trauma ICU, nutrition, medical oncology ICU, and shock trauma ICU. In addition to writing a manuscript for their major project, PGY2 Critical Care residents will submit a separate writing assignment for publication (i.e. case report, therapy review). Residents will have opportunities in serving as a primary responder on the code blue and stroke team and as the primary preceptor for one student in the Spring. Residents will also be involved in a longitudinal, monthly, outpatient rotation in our newly created Critical Care Recovery Clinic which opened in November 2023 and manage clinic patients upon hospital discharge as a way to bridge the gap between inpatient and outpatient care for critically ill patients.
Training amongst a group of 50 acute care, 12 ICU clinical specialists, and 26 other residents across the system, the resident will have ample learning and teaching opportunities including providing instruction to doctor of pharmacy students and mentoring PGY1 residents. The resident will provide an ACPE-accredited CE program and can participate in an optional teaching certificate program through the University of Houston College of Pharmacy.
Requests for PPS interviews will be answered after November 10, 2025
PGY2 Critical Care Residency Program Accolades 2023 ASHP Foundation Residency Excellence Award – Program Award 2019 Texas Society of Health-System Pharmacists Pharmacy Residency Program Excellence Award
Hospital Accolades 2024-2025 U.S. News & World Report – Best Hospitals Honor Roll 2024-2025 U.S. News & World Report - #1 Hospital in Texas (12 consecutive years) 2024 FORBES America’s Best Large Employers - #7 2024 ’Glassdoor‘ Best Places to Work - #37
Houston Methodist comprises seven community hospitals, a continuing care hospital as well as several emergency centers and physical therapy clinics throughout greater Houston. The flagship facility is a 900+ bed tertiary teaching hospital and is an academic affiliate of Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, New York Presbyterian Hospital, and many colleges of pharmacy. The flagship hospital in the Texas Medical Center is consistently ranked in multiple specialties by U.S. News and World Report and recognized as the No.1 hospital in Texas and Gulf Coast. Other regional Houston Methodist Hospitals are also very highly rated among Vizient comparable hospitals. HM is included on Forbes magazine's list of "America's Best Employers".